Seller
Your price
£99.80
RRP: £129.99
Save £30.19 (23%)
Printed on Demand
Dispatched within 14-21 working days.
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
Resistance to Targeted Anti-Cancer Therapeutics 15
Trade or Institutional customer? Contact us about large order quotes.
Synopsis
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance. New & Used
| Seller | Information | Condition | Price | |
|---|---|---|---|---|
 | - | New | £99.80 + FREE UK P & P |
What Reviewers Are Saying
Be the first to review this item.
Submit your review now